Hematologic Adverse Event Grading

Hematologic Adverse Event Grading is a standardized clinical assessment metric that classifies the severity of blood-related adverse reactions to therapeutic interventions according to predefined hematologic laboratory and clinical criteria.

18

Publications

882

Citations

176

Authors

103

Institutions

Publications per year

2017–2026

7

Authors

176

  1. MS
    Marion Subklewe

    Ludwig-Maximilians-Universität München, Germany

    2 publications · 124 citations

    2

    h-index

  2. KR
    Kai Rejeski

    Ludwig-Maximilians-Universität München, Germany

    2 publications · 124 citations

    2

    h-index

  3. RJ
    Richard J. Cook

    University of Waterloo, Canada

    1 publications · 55 citations

    1

    h-index

  4. MO
    Mark Olfson

    Feinstein Institute for Medical Research, United States

    1 publications · 51 citations

    1

    h-index

  5. KA
    Ken Awuondo

    Kenya Medical Research Institute, Kenya

    1 publications · 166 citations

    1

    h-index

1–5 of 176

Venues

  1. Current Therapeutic Research

    CTR · 1 publications · 70 citations

    1

    h-index

  2. Blood Advances

    1 publications · 69 citations

    1

    h-index

  3. Annals of Translational Medicine

    1 publications · 11 citations

    1

    h-index

  4. Clinical Immunology

    1 publications · 23 citations

    1

    h-index

  5. Asian Journal of Psychiatry

    1 publications · 14 citations

    1

    h-index

1–5